Clinical Trials Browser

Phase 3 × Recruiting × PM 01183 × Clear all

NCT06088290 2026-03-11

SaLuDo

Phase 3 Recruiting

Leiomyosarcoma, Neoplasms

NCT06203210 2026-03-02

IDeate-Lung02

Phase 3 Recruiting

Small Cell Lung Carcinoma

NCT06496048 2024-12-12

Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC

Phase 3 Recruiting

Small Cell Lung Carcinoma